---
title: "ZYPEEK: Currently, it has not directly involved in the field of humanoid robot applications"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/261385696.md"
description: "Regarding the market rumor that ZYPEEK is the exclusive supplier of joint bearings for Tesla's Optimus humanoid robot, ZYPEEK clarified that as of now, the company has not directly engaged in the field of humanoid robot applications and does not have the production capacity for humanoid robot parts. ZYPEEK emphasized that the company places great importance on downstream application fields with broad prospects, including humanoid robots"
datetime: "2025-10-16T07:29:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/261385696.md)
  - [en](https://longbridge.com/en/news/261385696.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/261385696.md)
---

# ZYPEEK: Currently, it has not directly involved in the field of humanoid robot applications

Regarding the market rumor that ZYPEEK (688716.SH) is the exclusive supplier of joint bearings for Tesla (TSLA.US) Optimus humanoid robots, ZYPEEK clarified that as of now, the company has not directly engaged in the field of humanoid robot applications and does not have the production capacity for humanoid robot parts.

ZYPEEK emphasized that the company places great importance on downstream application fields with broad prospects, including humanoid robots

### Related Stocks

- [688716.CN](https://longbridge.com/en/quote/688716.CN.md)

## Related News & Research

- [BYD is struggling to meet demand for new fast-charging EVs as orders reach 100K, 60K](https://longbridge.com/en/news/287109883.md)
- [Europe-China spacecraft launches to study Earth's 'invisible armour'](https://longbridge.com/en/news/286881963.md)
- [Apple Flavor to Buy NovoSana’s China Assets for Up to USD66 Million in Health Supplements Push](https://longbridge.com/en/news/287039106.md)
- [20:00 ETAccro Bioscience Announces $50 Million Series C Financing Led by OrbiMed to Advance Clinical Pipeline for Immune Mediated Diseases](https://longbridge.com/en/news/286830151.md)
- [Assessing NP3 Fastigheter (OM:NP3) Valuation After AGM Dividend Decisions And Board Changes](https://longbridge.com/en/news/286863209.md)